| ... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Trastuzumabum deruxtecanum | Enhertu | Powder for concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FD04 — ANTINEOPLASTIC AGENTS | € 2172.62 |
 skatīt informāciju par zālēm un iepakojumiem |
|
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Trastuzumabum | Herceptin | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FD01 — ANTINEOPLASTIC AGENTS | € 698.31 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Trastuzumabum | Herceptin | Solution for injection | 600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FD01 — ANTINEOPLASTIC AGENTS | € 2086.30 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) |
Reimbursed medicines reference product |
Trastuzumabum Biosimilar medicine |
Herzuma | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) Reimbursed medicines reference product |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Herzuma | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
NHS Reimbursed medicines |
Trastuzumabum emtansinum | Kadcyla | Powder for concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) NHS Reimbursed medicines |
L01FD03 — ANTINEOPLASTIC AGENTS | € 2055.65 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
NHS Reimbursed medicines |
Trastuzumabum emtansinum | Kadcyla | Powder for concentrate for solution for infusion | 160 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) NHS Reimbursed medicines |
L01FD03 — ANTINEOPLASTIC AGENTS | € 3285.36 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Kanjinti | Powder for concentrate for solution for infusion | 150 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Kanjinti | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) |
Reimbursed medicines reference product |
Trastuzumabum Biosimilar medicine |
Ogivri | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) Reimbursed medicines reference product |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ogivri | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) |
Next lowest cost medicine |
Trastuzumabum Biosimilar medicine |
Ontruzant | Powder for concentrate for solution for infusion | 150 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) Next lowest cost medicine |
L01FD01 — ANTINEOPLASTIC AGENTS | € 275.34 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ontruzant | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
NHS Reimbursed medicines |
Pertuzumabum, Trastuzumabum | Phesgo | Solution for injection | 1200 mg/600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) NHS Reimbursed medicines |
L01XY02 — ANTINEOPLASTIC AGENTS | € 10288.60 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
NHS Reimbursed medicines |
Pertuzumabum, Trastuzumabum | Phesgo | Solution for injection | 600 mg/600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) NHS Reimbursed medicines |
L01XY02 — ANTINEOPLASTIC AGENTS | € 5840.45 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Trazimera | Powder for concentrate for solution for infusion | 150 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Trazimera | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) |
Reimbursed medicines reference product |
Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) Reimbursed medicines reference product |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 60 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 101.88 |
skatīt informāciju par zālēm un iepakojumiem |
|
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Download search results (20 medicines) – ZIP archive containing the list in CSV, JSON and XML format. View list's field descriptions.
